Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8021687 | Modified release compositions of milnacipran A milnacipran formulation that provides delayed and extended release of milnacipran has been developed. The formulation comprises milnacipran or a salt thereof; an extended release excipient, and a delayed release excipient. The formulation provides, upon administra... | 09/20/2011 |
| 7771707 | Abuse-deterrent drug formulations An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, the drug is modified to increase its lipophilicity by forming a salt between ... | 08/10/2010 |
| 7704527 | Modified release compositions of milnacipran A milnacipran formulation that provides delayed and extended release of milnacipran has been developed. The formulation comprises milnacipran or a salt thereof; an extended release excipient, and a delayed release excipient. The formulation provides, upon administra... | 04/27/2010 |
| 7585520 | Compositions containing both sedative and non-sedative antihistamines and sleep aids Compositions containing both a sedative compound and a non-sedative antihistamine are provided. More particularly, compositions for administration at bedtime containing a sedating antihistamine or other sedating compound in immediate release form and a non-sedating ... | 09/08/2009 |
| 7399488 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, a drug is modified to increase its lipophilicity. In preferred embodiments th... | 07/15/2008 |
| 7387792 | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration New pharmaceutical compositions in unit dosage form are disclosed for both intraoral and oral administration to a patient, said unit dosage form configured to be placed intraorally of said patient, which comprises: (a) as a first p... | 06/17/2008 |
| 7309799 | Methods for the synthesis of milnacipran and congeners thereof One aspect of the present invention relates to methods for synthesizing milnacipran or congeners thereof. Another aspect of the present invention relates to asymmetric methods for synthesizing enantiomerically enriched milnacipran or congeners thereof. The present i... | 12/18/2007 |
| 7038085 | Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof The present invention relates generally to the enantiomers of para-hydroxy-milnacipran or congeners thereof. Biological assays revealed that racemic para-hydroxy-milnacipran is approximately equipotent in inhibiting serotonin and norepinephrine uptake (IC50 | 05/02/2006 |
| 6863901 | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration New pharmaceutical compositions in unit dosage form are disclosed for both intraoral and oral administration to a patient, said unit dosage form configured to be placed intraorally of said patient, which comprises: (a) as a first p... | 03/08/2005 |
| 6827946 | Compositions containing both sedative and non-sedative antihistamines Compositions comprising both a sedative and a non-sedative antihistamine are disclosed as well as methods of inhibiting the release of histamines by administration of the compositions to a mammalian subject. ... | 12/07/2004 |